Feb 1, 2008

Nectar Design Signs on to Create Groundbreaking Medicine Dispenser for The Releef Initiative.

Nectar Design is pleased to announce that it will create the preliminary design for a revolutionary, hand-held pharmaceutical dispenser on behalf of an international non-profit, The Releef Initiative.  Nectar, an award-winning industrial design and product development consultancy, is currently developing the early prototypes for customer feedback and feasibility research.  Read more...

 

 

Oct 22, 2007

The Releef Initiative Announces Plans to Raise Funding for  A New Product Development Program.

The group announced its plans to start raising funds for the development of a generic formulation for drugs and micronutrients in conjunction with an innovative packaging and dispensing technology. Based on this platform the organization intends to launch several health care products in the future. Read more...

 

 

Oct 1, 2007

The Releef Initiative Forms a Networking Group on Linkedin.

This professional group is meant to be a gathering point for people of all disciplines and backgrounds that have an interest in facilitating exchange of ideas and contacts on topics relating to: global health, neglected diseases, and product development for under-served geographies. Read more...

July 2, 2008

“Releef” is on the way

Article in Long Beach Press by Joe Stevens

Doctors in Third World countries often have a peculiar way of giving medicine to babies. They snap a pill in half, or into quarters, and pray they dole out the desired amount. So any time a specific small amount is required, that can be problematic. It is something that Long Beach- based Nectar addressed in one of its designs. Read the article...

 

 

March 16, 2008

New Publication from Releef’s Scientists.

This week an article about the beneficial effects of a drug combination for treatment of tissue wasting was published in Oncology Reports. The authors of the report, Dr Kenley and collaborators describe the effects of two well known pharmaceutical agents, formoterol and roxithromycin. The experiments points to a synergistic effect in slowing cachexia or tissue wasting which is a common medical problem in cancer, infections and traumatic injuries. Read more…

 

 

 

Home    |     About Us     |     R&D     |     News & Media     |     Participate     |     Contact Us  

the

initiative

ReLeef

News & Media Highlights

March 2, 2009

The Releef Initiative has registered a subsidiary in Sweden

The Releef Initiative operates as a virtual R&D organization, where an experienced management team focuses cost-effective product development on proven efficacy together with extreme safety, low cost manufacturing and distribution in low-income settings. By establishing a subsidiary in Sweden, Releef can more effectively advance its lead projects to the point of customer value. Read more...